ArticleKidney international reports2026
Perirenal Adipose Tissue may be an Important Predictor of Adverse Kidney Outcomes in Living Kidney Donors.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Introduction: Obesity is a growing concern among living kidney donors (LKDs), with perirenal adipose tissue (PRAT) increasingly recognized as a key contributor to chronic kidney disease (CKD) risk. This study evaluates PRAT thickness in relation to kidney function, hypertension, and histological markers of fibrosis in LKDs. Methods: We retrospectively analyzed 3226 LKDs from Mayo Clinic Minnesota and Arizona (2000-2019) with implantation kidney biopsies and predonation computed tomography (CT) angiograms. PRAT thickness was measured posteriorly and laterally from the retained kidney at the renal vein level and perirenal fat stranding (PFS) was graded. Histological assessments included nonsclerosed glomeruli, globally sclerosed glomeruli (GSG), interstitial fibrosis and tubular atrophy (IFTA), and luminal stenosis. Results: PRAT thickness and PFS increased with older age, especially in men. Black donors had the lowest PRAT and PFS measures. Compared with normotensive donors, donors with hypertension had significantly higher body mass index (BMI) (29.5 kg/m Conclusion: PRAT thickness was a stronger predictor of postdonation renal outcomes than BMI. Incorporating PRAT assessment into donor evaluation may improve risk stratification and identify therapeutic targets for reducing CKD risk in LKDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.